Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis

Tuberculosis remains the biggest infectious threat to humanity with one-third of the population infected and 1.4 million deaths and 8.7 million new cases annually. Current tuberculosis therapy is lengthy and consists of multiple antimicrobials, which causes poor compliance and high treatment dropout...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Bhattacharya, Debapriya, Dwivedi, Ved Prakash, Maiga, Mamoudou, Maiga, Mariama, Van Kaer, Luc, Bishai, William R., Das, Gobardhan
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Biochemistry and Molecular Biology 2014
נושאים:
Immunology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4047417/
https://ncbi.nlm.nih.gov/pubmed/24711459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M114.558098
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים